Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-pd-1 Antibody”

593 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 593 results

Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Early research (Phase 1)Active Not RecruitingNCT05354323
What this trial is testing

NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors

Who this might be right for
Solid Tumors, Adult
NEC OncoImmunity AS 6
Early research (Phase 1)Study completedNCT03713905
What this trial is testing

Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Guangzhou Gloria Biosciences Co., Ltd. 293
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07515469
What this trial is testing

A Prospective, Single-Arm, Exploratory Study of the Safety and Efficacy of Neoadjuvant Treatment With QL1706, an Anti-PD-1/Anti-CTLA-4 Bispecific Antibody, in Resectable Stage IB and IIA Hepatocellular Carcinoma With High Recurrence Risk

Who this might be right for
HCC - Hepatocellular CarcinomaIparomlimab and Tuvonralimab InjectionNeoadjuvant Immunotherapy
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05311566
What this trial is testing

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

Who this might be right for
Cervical CarcinomaChemoradiotherapyAnti-programmed Cell Death Receptor 1+6 more
Lei Li 92
Testing effectiveness (Phase 2)UnknownNCT04918628
What this trial is testing

Adjuvant Chemotherapy and Anti-PD-1 Antibody in Patients With Stage IIIC2-IVB Cervical Cancer

Who this might be right for
Cervical Cancer
Taizhou Hospital 50
Early research (Phase 1)Study completedNCT01358721
What this trial is testing

Phase I Biomarker Study (BMS-936558)

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 119
Not applicableLooking for participantsNCT05717738
What this trial is testing

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Tongji Hospital 300
Not applicableNot Yet RecruitingNCT06682247
What this trial is testing

A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Feng Wang 200
Testing effectiveness (Phase 2)UnknownNCT02942329
What this trial is testing

Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer

Who this might be right for
Gastric CancerHepatocellular Carcinoma
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 60
Testing effectiveness (Phase 2)Ended earlyNCT04952753
What this trial is testing

Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC

Who this might be right for
Metastatic Colorectal Cancer
Novartis Pharmaceuticals 204
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05732662
What this trial is testing

SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCC

Who this might be right for
Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
The First People's Hospital of Changzhou 25
Large-scale testing (Phase 3)UnknownNCT03952403
What this trial is testing

HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
CarcinomaNon-Small-Cell Lung
Shanghai Henlius Biotech 643
Testing effectiveness (Phase 2)Study completedNCT03003468
What this trial is testing

Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017

Who this might be right for
Non-Small Cell Lung Cancer
Lawrence Feldman, MD 35
Testing effectiveness (Phase 2)Looking for participantsNCT06349980
What this trial is testing

Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Henlius Biotech 117
Early research (Phase 1)Not Yet RecruitingNCT06934616
What this trial is testing

A Phase I, First-in-Human Study of GB268 (PD-1/CTLA-4/VEGF Trispecific Antibody) in Advanced Solid Tumors

Who this might be right for
Solid Tumor Cancer
Genor Biopharma Co., Ltd. 330
Testing effectiveness (Phase 2)Study completedNCT04301778
What this trial is testing

Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma

Who this might be right for
Unresectable Intrahepatic Cholangiocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05522985
What this trial is testing

Neoadjuvant Chemotherapytreatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaNeoadjuvant Chemotherapy
Tianjin Medical University Cancer Institute and Hospital 122
Testing effectiveness (Phase 2)UnknownNCT05675033
What this trial is testing

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

Who this might be right for
Lung AdenocarcinomaStage IV Non-small Cell Lung CancerPD-1 Inhibitor+1 more
Fujian Cancer Hospital 50
Early research (Phase 1)UnknownNCT02836834
What this trial is testing

Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors

Who this might be right for
LymphomaLung Cancer
Shanghai Junshi Bioscience Co., Ltd. 33
Load More Results